SV2A and Alzheimer disease: Compared with NCs, SV2A levels were lower in the AD patients at Braak stages III–IV, as well as at Braak stages V–VI (Fig. 4c, P = 0.0385, P = 0.0031), but not in the AD patients at Braak stages 0–II.